Purple Biotech Ltd Total Liabilities

Latest as of September 2025: ILA6.25 Million ILA ≈ $16.75K USD

Purple Biotech Ltd total liabilities. Based on the latest financial reports, Purple Biotech Ltd (PPBT) has total liabilities worth ILA6.25 Million ILA (≈ $16.75K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PPBT asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Purple Biotech Ltd (2017–2024)

Total liabilities of Purple Biotech Ltd from 2017 to 2024. This chart illustrates how Purple Biotech Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Purple Biotech Ltd to see how much of total assets are deployed in long-term investments.

Purple Biotech Ltd Competitors by Total Liabilities

The table below lists competitors of Purple Biotech Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Stenocare AS CO:STENO	Denmark	Dkr3.73 Million
GLOBAL UAV TECHS F:YAB	Germany	€1.48 Million
ABM International Limited NSE:ABMINTLLTD	India	Rs-135.28 Million
PVW Resources Ltd AU:PVW	Australia	AU$1.02 Million
AquaBounty Technologies Inc NASDAQ:AQB	USA	$12.38 Million
Kalgoorlie Gold Mining Ltd AU:KAL	Australia	AU$579.57K
Core AI Holdings NASDAQ:CHAI	USA	$22.83 Million
ArcWest Exploration Inc V:AWX	Canada	CA$989.09K

Liability Composition Analysis (2017–2024)

This chart breaks down Purple Biotech Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PPBT asset base.

Liquidity & Leverage Metrics

Purple Biotech Ltd Total Liabilities Ratios Explained

Purple Biotech Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.78	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Purple Biotech Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Purple Biotech Ltd (2017–2024)

The table below shows the annual total liabilities of Purple Biotech Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	ILA4.13 Million ≈ $11.06K	-58.75%
2023-12-31	ILA10.01 Million ≈ $26.82K	+32.97%
2022-12-31	ILA7.52 Million ≈ $20.17K	+47.76%
2021-12-31	ILA5.09 Million ≈ $13.65K	+25.70%
2020-12-31	ILA4.05 Million ≈ $10.86K	+4.98%
2019-12-31	ILA3.86 Million ≈ $10.35K	+3.76%
2018-12-31	ILA3.72 Million ≈ $9.97K	-33.47%
2017-12-31	ILA5.59 Million ≈ $14.99K	--

About Purple Biotech Ltd

TA:PPBT Israel Biotechnology

Market Cap

$4.84 Million

ILA1.81 Billion ILA

Market Cap Rank

#28584 Global

#414 in Israel

Share Price

ILA1.00

Change (1 day)

+0.00%

52-Week Range

ILA1.00 - ILA1.30

All Time High

ILA3676.00